28 . May , 2020 - Thursday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Hypaque

Big Image
Generic Name: diatrizoate sodium
Dosage Form: Oral powder

For Examination of the Gastrointestinal Tract



Hypaque Description

Hypaque Sodium (Diatrizoate Sodium, USP) is sodium 3,5-diacetamido-2, 4, 6-triiodobenzoate (C11H8I3N2NaO4) and contains 59.87 percent iodine. It is available as a powder. The powder (for preparing radiopaque solutions) provides about 600 mg organically bound iodine per gram of powder and contains caramel as a coloring agent. The structural formula is as follows:

Inactive Ingredients: Caramel, Polysorbate 80.

Hypaque - Clinical Pharmacology

When administered orally or given as an enema, the medium produces excellent opacification and delineation of the upper and lower gastrointestinal tract; however, because of dilution, contrast in the small bowel may be unsatisfactory. Hypaque solutions are particularly valuable when a more viscous agent, such as barium sulfate which is not water soluble, is unsuitable or potentially harmful.

From 0.04 to 1.2 percent of the medium may be absorbed from the gastrointestinal tract after oral administration. In some patients, particularly in infants and patients with engorgement of the intestinal mucosa, sufficient absorption to cause some visualization of the urinary tract may occur occasionally. Hypaque is also absorbed across the peritoneum and pleura.

Indications and Usage for Hypaque

This medium is indicated for radiographic examination of the gastrointestinal tract following oral or rectal administration.



Severe adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use. These serious adverse reactions include: death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. Special attention must be given to insure that this drug product is not administered intrathecally.

Serious or fatal reactions have been associated with the parenteral administration of radiopaque media. It is important that a course of action be carefully planned in advance for the treatment of possible serious reactions with oral use of Hypaque solutions. (See Precautions.)

Usage in Pregnancy

The safety of orally administered Hypaque solutions during pregnancy has not been established. Therefore, before administration of the drug to women of childbearing potential, the benefit to the patient should be carefully weighed against the possible risk to the fetus. In addition, most authorities consider elective contrast radiography of the abdomen contraindicated during pregnancy.


A 10 percent solution of the medium in water is isotonic. Hence, the solutions generally employed clinically (ie, from 15 to 40 percent) are hypertonic. Highly hypertonic solutions may draw excessive amounts of fluid into the intestine and may lead to hypovolemia. In very young or debilitated children, and in elderly cachectic persons, the loss of plasma fluid may be sufficient to cause a shock-like state which, if untreated, could be dangerous to the patient. Wherever possible, the use of the lower concentrations is advised for infants and young children (under 10 kg) and for dehydrated or debilitated patients. The higher concentrations should be used in such patients only when necessary and with great caution.

Therefore, it is advisable to correct any electrolyte disturbances before using solutions that are extremely hypertonic and to promptly correct hypovolemic disturbance caused by the medium.

Bronchial entry of the medium causes a copious osmotic effusion. Therefore, pulmonary entry by aspiration or by use in patients with esophagotracheal fistula should be avoided.

Caution is also advised in patients with severe renal or hepatic disease.

In patients with known hypersensitivity to diatrizoic acid compounds, the benefit to risk ratio should be considered.

Adverse Reactions

There have been few reported cases of adverse reactions with orally administered solutions of water-soluble contrast agents. Because of their osmotic effect, such solutions tend to exert cathartic action, but this is generally considered an advantage. Nausea, vomiting, or slight diarrhea may occasionally occur, particularly when the medium is used in a high concentration or large volume. Urticaria has been observed in a few patients; presumably the condition was caused by allergy to the contrast medium and it was readily alleviated by antihistamine therapy.

Because small amounts of the medium may be absorbed, the possibility of systemic reactions should be considered, particularly in cases of perforation.

Hypaque Dosage and Administration


Oral, from 90 mL to 180 mL of a 25 to 40 percent solution.

Enema, from 500 mL to 1000 mL of a 15 to 25 percent solution.

Infants and Children

Oral, from 30 mL to 75 mL of a 20 to 40 percent solution.

Enema, from 100 mL to 500 mL of a 10 to 15 percent solution, depending on weight of patient.


The powder is not to be used for the preparation of solution for parenteral injection.

Directions for Making Solutions from Hypaque Powder
Measuring spoons* of powder
(per 100 mL diluent )
One level measuring spoon is equal to approximately 10 g of powder.
Solutions may be sweetened or flavored (eg, with vanilla, lemon, chocolate); the diluent may be water, milk, or a carbonated drink. Carbonated diluents should be avoided when gas artifacts are undesirable.
The resulting solution should be used upon preparation; do not store for future use.
10 1
15 1 1/2
20 2
25 2 1/2
40 4

How is Hypaque Supplied

Hypaque Oral Powder contains 59.87 percent iodine or about 600 mg iodine per g.

Hypaque Oral Powder—Cans of 250 g with measuring spoon (approximately 10 g capacity), NDC 0407-0769-01.

Store in the dark at 20°-25°C (68°-77°F). [See USP controlled room temperature.]

Distributed by Amersham Health Inc.
Princeton, NJ 08540

Printed in USA

August 2004

Hypaque Sodium (Diatrizoate Sodium)
Product Code 0407-0769 Dosage Form POWDER, FOR SOLUTION
Route Of Administration ORAL DEA Schedule
Name (Active Moiety) Type Strength
Diatrizoate Sodium (Iodine) Active 600 MILLIGRAM  In 1 GRAM
Caramel Inactive  
Polysorbate 80 Inactive  
Characteristic Appearance Characteristic Appearance
Color Score
Shape Symbol
Imprint Code Coating
# NDC Package Description Multilevel Packaging
1 0407-0769-01 250 GRAM In 1 CAN None

Revised: 02/2006

Recent Drug Updates at DrugIndexOnline:

brompheniramine, hydrocodone, and pseudoephedrine brompheniramine, hydrocodone, and pseudoephedrine
Generic Name: brompheniramine, hydrocodone, and pseudoephedrine (brom fen EER a meen, hye droe KOE dohn, soo doe e FED rin) Brand Names: Anaplex HD What is brompheniramine, hydrocodone, and pseudoephedrine? Brompheniramine is an antihistamine that reduces the natural chemical histamine i more...

Denorex Extra Strength Medicated Shampoo with Conditioners Topical Denorex Extra Strength Medicated Shampoo with Conditioners Topical
Some commonly used brand names are: In the U.S.— Alphosyl Aquatar Balnetar Therapeutic Tar Bath Cutar Water Dispersible Emollient Tar Denorex Extra Strength Medicated Shampoo Denorex Extra Strength Medicated Shampoo with Conditioners Denorex Medicated Shampoo Denorex Medicated Shampoo and more...

dorzolamide and timolol ophthalmic dorzolamide and timolol ophthalmic
Generic Name: dorzolamide and timolol ophthalmic (dor ZOLE a mide and TYE moe lole) Brand Names: Cosopt What is dorzolamide and timolol ophthalmic? Dorzolamide ophthalmic reduces the amount of fluid in the eye, which decreases pressure inside the eye. Timolol ophthalmic is a beta-blocker more...

Fluconazole Suspension Fluconazole Suspension
Generic Name: Fluconazole Oral Suspension (flue-KON-a-zole) Brand Name: DiflucanFluconazole Suspension is used for:Treating and preventing certain yeast and fungal infections. It may also be used for other conditions as determined by your doctor. Fluconazole Suspension is an azole antifungal. It more...

Hydergine Hydergine
Generic Name: Ergoloid Mesylates Tablets (ER-goe-loid MES-i-lates) Brand Name: HydergineHydergine is used for:Treating symptoms of declined mental capacity (memory, mood, and behavior problems) in certain patients older than 60 years of age. It may also be used for other conditions as determine more...

Mykacet Mykacet
Some commonly used brand names are: In the U.S.— Dermacomb Myco II Mycobiotic II Mycogen II Mycolog II Myco-Triacet II Mykacet Mykacet II Mytrex Tristatin II Generic name product may be available in the U.S. † Not commercially available in Canada. Category Antifungal-corticost more...

Nilutamide Nilutamide
Generic name: Nilutamide Brand names: Nilandron Why is Nilutamide prescribed? Nilandron is used for advanced prostate cancer--cancer that has begun to spread beyond the prostate gland. An "antiandrogen" drug, it blocks the effects of the male hormone testosterone, which is known to encourage pro more...

Palladone Palladone
Note: Palladone (hydromorphone hydrochloride extended release capsules) was suspended from the U.S. market in July 2005 by the manufacturer. Serious side effects were reported when Palladone was taken with alcohol. Some commonly used brand names are: In the U.S.— Astramorph PF 10 more...